MiR-146a encapsulated liposomes reduce vascular inflammatory responses through decrease of ICAM-1 expression, macrophage activation, and foam cell formation

Treatment of microRNA-146a encapsulated liposomes reduces vascular inflammation by targeting multiple related components including endothelial cell, smooth muscle cell, and macrophage activation as well as foam cell formation.